XTANDI
XTANDI
Approved
DIN Number
02407329
Drug Class
Human
Market Date
Jun 7, 2013
Company
HC
astellas pharma canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02407329
AIG Number0154350001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L02BB04 ENZALUTAMIDE
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
ENZALUTAMIDEActive
Strength: 40 MG
Monograph: ENZALUTAMIDE